Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mechanisms initiating platelet thrombus formation

Z M Ruggeri1

  • 1Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037, USA. ruggeri@scripps.edu

Thrombosis and Haemostasis
|July 1, 1997
PubMed
Summary

Platelets aggregate to stop bleeding but can cause disease when blocking arteries. Understanding how von Willebrand factor and platelet receptors interact under shear stress is key for new anti-thrombotic therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interaction of von Willebrand factor with platelets and the vessel wall.

Hamostaseologie·2015
Same author

Genetic deletion of platelet glycoprotein Ib alpha but not its extracellular domain protects from atherosclerosis.

Thrombosis and haemostasis·2014
Same author

Contributions of thrombin targets to tissue factor-dependent metastasis in hyperthrombotic mice.

Journal of thrombosis and haemostasis : JTH·2013
Same author

Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood.

Journal of thrombosis and haemostasis : JTH·2010
Same author

Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis.

Journal of thrombosis and haemostasis : JTH·2006
Same author

Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.

Journal of thrombosis and haemostasis : JTH·2006

Area of Science:

  • Biochemistry
  • Hematology
  • Biophysics

Background:

  • Platelet function is crucial for hemostasis but can lead to thrombotic diseases like atherosclerosis.
  • Fluid dynamics significantly influence platelet interactions at sites of vascular injury.
  • Von Willebrand factor is essential for platelet adhesion and aggregation under high shear stress.

Purpose of the Study:

  • To explore the biomechanical properties of platelet receptors involved in von Willebrand factor-mediated thrombus formation.
  • To elucidate the synergistic roles of glycoprotein complexes Ib-IX-V and IIb-IIIa in platelet aggregation.
  • To establish a pathophysiological basis for developing novel anti-thrombotic strategies.

Main Methods:

  • Analysis of platelet adhesion and aggregation under varying shear stress conditions.

Related Experiment Videos

  • Investigation of the structure and function of von Willebrand factor binding domains.
  • Characterization of platelet membrane receptors, glycoprotein Ib-IX-V and IIb-IIIa (integrin alpha IIb beta 3).

    • Main Results:

    • Von Willebrand factor acts as a critical adhesive protein mediating platelet function at high shear stress.
    • Glycoprotein complexes Ib-IX-V and IIb-IIIa coordinate to facilitate von Willebrand factor-dependent platelet adhesion and aggregation.
    • Each receptor contributes distinct biomechanical properties essential for thrombus development.

    Conclusions:

    • Understanding the molecular mechanisms of von Willebrand factor-platelet receptor interactions is vital for hemostasis and thrombosis.
    • Targeting these interactions offers a promising avenue for novel anti-thrombotic therapies.
    • Further research into binding sites and mechanisms will advance the evaluation of new anti-thrombotic strategies.